Biocon Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biocon Limited with three other
pharmaceutical manufacturers in Asia:
China Animal Husbandry Ind.
sales of 3.97 billion Chinese Renmimbi [US$576.77 million]
of which 48%
was Animal Feedstuff),
of South Korea
(670.58 billion Korean Won [US$598.83 million]
of which 86%
was Bio Business Division), and
Yifan Pharmaceutical Co Ltd
based in China
(3.50 billion Chinese Renmimbi [US$508.56 million]
of which 67%
was Health Products - Medicine).
Biocon Limited reported sales of 34.85 billion Indian Rupees (US$538.15 million)
March of 2016.
increase of 12.8%
versus 2015, when the company's sales were 30.90 billion Indian Rupees.
This was the fourth straight year of sales growth at Biocon Limited.
Sales of Research Services saw an increase
that was more than double the company's growth rate: sales were up
28.8% in 2016, from
8.40 billion Indian Rupees to 10.81 billion Indian Rupees.